HIMS
Hims Hers Health Inc
$26.10
+11.21%
Price vs Sales Yield
Current Valuation
- Sales Yield
- 41.15%
- P/S
- 2.4x
- P/E Ratio
- 46.0x
- PEG Ratio
- 2.61
P/S Averages
- Median (Fair Value)
- 2.8x
- Industry (Damodaran)
- 5.6x
- 1-Year Avg
- 2.0x
- 3-Year Avg
- 1.7x
- 5-Year Avg
- 1.7x
- Min / Max
- 1.3x / 8.6x
Revenue Growth
- YoY Growth
- 49.2%
- 3-Year CAGR
- 60.5%
- 5-Year CAGR
- 70.7%
Financial Snapshot
- Market Cap
- $5.35B
- Enterprise Value
- $5.89B
- Revenue (TTM)
- $2.35B
- Dividend Yield
- -
Valuation Context
vs 5-Year Average
41%
Above average (potentially overvalued)
Sales Yield
41.15%
High yield
vs Industry (Drugs (Pharmaceutica...)
-57%
Below industry avg
Data Points
1253
daily data points